Phl Airport: Covid Testing Availability And Accessibility

In December 2020, Philadelphia International Airport (PHL) launched a COVID-19 testing program in partnership with Jefferson Health and Ambulnz. The program, which is designed for asymptomatic passengers flying out of PHL, offers multiple testing options, including antigen and Polymerase Chain Reaction (PCR) tests, with results available via text. The testing facility is located in the Terminal E Departures building and is equipped with medically appropriate air filtration and circulation, as well as private offices for travellers.

Testing is for asymptomatic passengers flying out of PHL

Philadelphia International Airport (PHL) has launched a COVID-19 testing program in partnership with Jefferson Health and Ambulnz. The program, which began on December 4, 2020, is designed for asymptomatic passengers flying out of PHL and will provide travellers with the confidence to move safely between destinations.

The testing program is located in the Terminal E Departures building and offers multiple testing options, including an antigen test, a Polymerase Chain Reaction (PCR) test, and a Rapid PCR test (planned for the future). The testing facility has been equipped with medically appropriate air filtration and circulation, as well as a private office setting for each passenger. Results from the antigen test will be texted to passengers on the same day, while the standard PCR test results will be available within 48 to 72 hours. The testing options range in price from $70 to $130, making the PHL program one of the most affordable in the country. Parking in the Terminal E Parking Garage will be complimentary for up to 2 hours for those undergoing testing.

The program is administered by Jefferson Health via Rapid Reliable Testing, the COVID response division of Ambulnz, a joint venture with Jefferson. The program has been designed to scale up as demand increases, and additional testing locations have been identified at PHL for future expansion.

The availability of COVID-19 testing at PHL will enable the airport to expand connections with destinations that require testing prior to arrival, such as many Caribbean locations, which is one of PHL's largest destination markets during the winter season.

Multiple testing options are available

Philadelphia International Airport (PHL) has launched a COVID-19 testing program in partnership with Jefferson Health and Ambulnz. The testing program is located in the Terminal E Departures building and is designed for asymptomatic passengers flying out of PHL.

The antigen test option provides same-day results via text, while the standard PCR test provides results within 48 to 72 hours, also via text. The Rapid PCR test is expected to provide results within a similar timeframe as the standard PCR test. The cost of testing ranges from $70 to $130, making it one of the most affordable testing programs in the country.

The testing program is administered by Jefferson Health via Rapid Reliable Testing, the COVID response division of Ambulnz, a joint venture with Jefferson. The program has been designed to scale up as demand increases, with additional testing locations identified and to be announced in the future.

Results are sent via text

Philadelphia International Airport (PHL) has launched a COVID-19 testing program in partnership with Jefferson Health and Ambulnz. The testing program is located in the Terminal E Departures building and is designed for asymptomatic passengers flying out of PHL.

The testing program offers multiple testing options, including an antigen test, a Polymerase Chain Reaction (PCR) test, and a Rapid PCR test planned in the future. The test options range in price from $70 to $130, making the PHL program one of the most affordable in the country. Results are sent via text to passengers the same day for antigen tests, and within 48 to 72 hours for the standard PCR test.

The testing facility has been equipped with medically appropriate air filtration and circulation, as well as a private office setting for each passenger. The program has been designed to scale up as demand increases, and additional testing locations have been identified at PHL, to be announced when available.

The availability of COVID-19 testing at PHL enables the airport to expand connections with destinations that require testing prior to arrival. For example, passengers travelling to many Caribbean destinations, which represent one of PHL's largest destination markets in the winter season, must produce a negative PCR test result administered within the previous 72 hours as a condition for boarding a plane.

The testing program at PHL is a collaboration between Jefferson Health, which administers the tests, and Ambulnz, a private ambulance company that is the largest responding to COVID-19 in New York City.

Parking is complimentary for up to 2 hours for testing patrons

Philadelphia International Airport (PHL) has partnered with Jefferson Health and Ambulnz to launch a COVID-19 testing program. The program, which is designed for asymptomatic passengers flying out of PHL, offers multiple testing options, including antigen tests, Polymerase Chain Reaction (PCR) tests, and Rapid PCR tests. The testing facility is located within the PHL Terminal E Departures building, equipped with medically appropriate air filtration and circulation, as well as private offices for individual passengers.

To make the testing program more accessible, parking in the Terminal E Parking Garage is complimentary for up to 2 hours for those undergoing COVID-19 testing. This complimentary parking offer is a convenient option for testing patrons, ensuring that they do not incur parking fees during their brief visit to the airport solely for testing purposes. The testing program itself is also among the most affordable in the country, with prices ranging from $70 to $130, depending on the type of test chosen.

The COVID-19 testing service at PHL is a valuable amenity for travellers, particularly those heading to destinations that require a recent negative test result, such as many Caribbean destinations. By providing testing at the airport, passengers can conveniently fulfil the prerequisite testing requirements before their flights. This service enhances PHL's connectivity with various destinations, making it safer and more accessible for travellers to explore different locations.

The testing program at PHL is a collaborative effort between Jefferson Health, Ambulnz, and the airport authorities. Jefferson Health administers the testing through its Rapid Reliable Testing division, a joint venture with Ambulnz. Ambulnz, a private ambulance company, brings its expertise in medical transportation and COVID-19 response to the partnership. Together, they aim to support travellers' safety and confidence while promoting economic recovery in the region.

In summary, the availability of COVID-19 testing at Philadelphia International Airport, complemented by complimentary parking for testing patrons, facilitates safer travel and expands the airport's reach to new destinations. The partnership between Jefferson Health and Ambulnz ensures a reliable and accessible testing program that contributes to the overall well-being of the travelling community.

The testing facility is equipped with medically appropriate air filtration and circulation

Philadelphia International Airport (PHL) has partnered with Jefferson Health and Ambulnz to launch a COVID-19 testing program. The testing facility is equipped with medically appropriate air filtration and circulation, as well as a private office setting for each passenger.

The testing facility, located in the Terminal E Departures building, has been designed with the necessary medical-grade air filtration systems to ensure the safety and well-being of both passengers and staff. The air filtration and circulation system plays a critical role in maintaining indoor air quality by removing airborne contaminants, including viruses and bacteria, and preventing their spread. This is particularly important in the context of COVID-19, as the virus can be transmitted through respiratory droplets and aerosols.

Medically appropriate air filtration systems typically combine multiple technologies to ensure effective air purification. High-efficiency particulate air (HEPA) filters, for example, are commonly used in medical settings as they can capture at least 99.97% of airborne particles, including viruses and bacteria. Additionally, the use of ultraviolet (UV) light technology in conjunction with HEPA filters can further enhance the effectiveness of the air filtration system by inactivating viruses and bacteria.

The air circulation aspect of the system is equally important as it ensures proper ventilation and prevents stagnant air. Adequate air circulation helps to dilute and remove airborne contaminants, reducing the risk of exposure and supporting the overall health and comfort of individuals within the testing facility.

By implementing medically appropriate air filtration and circulation systems, the PHL COVID-19 testing facility aligns with recommended guidelines and ensures a safe environment for passengers and staff alike. This comprehensive approach to testing facility design demonstrates PHL's commitment to providing a secure and healthy space for travellers during the pandemic.

Frequently asked questions